The chemopreventive effect of withaferin A on spontaneous and inflammation-associated colon carcinogenesis models

Autor: Murali K. Ankem, Arun Sharma, Becca V. Baby, Deeksha Pal, Houda Alatassi, Ashish Tyagi, Nisha Dahiya, Khafateh Youssef, Balaji Chandrasekaran, Chendil Damodaran, Venkatesh Kolluru
Rok vydání: 2018
Předmět:
Zdroj: Carcinogenesis. 39:1537-1547
ISSN: 1460-2180
0143-3334
DOI: 10.1093/carcin/bgy109
Popis: Chemopreventive effects and associated mechanisms of withaferin A (WA) against intestinal and colon carcinogenesis remain unknown. We investigated the chemopreventive effect of WA on transgenic adenomatous polyposis coli (APC(Min/+)) mouse and chemically induced azoxymethane/dextran sodium sulfate (AOM/DSS) models of intestinal and colon carcinogenesis. Oral WA administration (4 and 3 mg/kg) inhibited tumor initiation and progression of intestinal polyps formation in APC(Min/+) mice and colon carcinogenesis in the AOM/DSS mouse model. WA-administered mice showed a significant reduction in both number [duodenum, 33% (P > 0.05); jejunum, 32% (P < 0.025); ileum, 43% ( P < 0.001); and colon 59% (P < 0.01] and size of polyps in APC(Min/+) mice compared with the respective controls. Similarly, tumor multiplicity was significantly reduced (P < 0.05) in the colon of WA-administered AOM/DSS mice. Pathological analysis showed reduced adenomas and tissue inflammation in WA-administered mouse models. Molecular studies suggested that WA inhibited the expression of inflammatory (interluekin-6, tumor necrosis factor-alpha and cyclooxygenase-2), pro-survival (pAKT, Notch1 and NF-κB) markers in APC(Min/+) and AOM/DSS models. The results suggest that WA is a potent agent for preventing colon carcinogenesis and further investigation is required to show clinical utility of the agent.
Databáze: OpenAIRE